Smoldering Myeloma High-Risk Patient Observation and Longitudinal Insight Trial
Condition(s):Smoldering Multiple MyelomaLast Updated:January 31, 2024Recruiting
Hide Studies Not Open or Pending
Condition(s):Smoldering Multiple MyelomaLast Updated:January 31, 2024Recruiting
Condition(s):Smoldering Multiple MyelomaLast Updated:February 12, 2024Active, not recruiting
Condition(s):Asymptomatic MyelomaLast Updated:March 3, 2020Terminated
Condition(s):Smoldering Multiple MyelomaLast Updated:October 17, 2023Recruiting
Condition(s):Smoldering Multiple MyelomaLast Updated:June 13, 2023Completed
Condition(s):Smoldering Multiple MyelomaLast Updated:August 1, 2023Active, not recruiting
Condition(s):Smoldering Multiple MyelomaLast Updated:January 12, 2024Not yet recruiting
Condition(s):High Risk Smoldering Multiple MyelomaLast Updated:December 16, 2020Terminated
Condition(s):Smoldering Myeloma; Smoldering Multiple MyelomaLast Updated:June 9, 2023Completed
Condition(s):Smoldering Multiple MyelomaLast Updated:May 9, 2014Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.